Tebao Biotechnology: Net profit in the first quarter of 2026 was 164 million yuan, a decrease of 9.68% year-on-year.

Tebao Life Science announced that its operating income in the first quarter of 2026 was 798 million yuan, an increase of 18.48% year-on-year. The net profit attributable to shareholders of the listed company was 164 million yuan, a decrease of 9.68% year-on-year. The basic earnings per share was 0.40 yuan/share, a decrease of 11.11% year-on-year.